Universal Health Services (UHS) Financials

$190.94 +0.56 (+0.29%)

Closing price 03:59 PM Eastern

Extended Trading

$191.04 +0.10 (+0.05%)

As of 04:16 PM Eastern

Annual Income Statements for Universal Health Services

This table shows Universal Health Services' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Income / (Loss) Attributable to Common Shareholders	1,142	718	676	992	944	815	780	752	702	681
Consolidated Net Income / (Loss)	1,163	719	657	988	953	828	798	771	747	751
Net Income / (Loss) Continuing Operations	1,163	719	657	988	953	828	798	771	747	751
Total Pre-Tax Income	1,498	940	866	1,293	1,252	1,066	1,035	1,135	1,156	1,146
Total Operating Income	1,682	1,175	1,004	1,363	1,358	1,216	1,175	1,280	1,281	1,259
Total Gross Profit	8,309	7,174	6,637	6,478	5,946	5,789	5,518	5,429	5,181	4,831
Total Revenue	15,828	14,282	13,399	12,642	11,559	11,378	10,772	10,410	9,766	9,043
Operating Revenue	15,828	14,282	13,399	12,642	11,559	11,378	10,772	10,410	9,766	9,043
Total Cost of Revenue	7,519	7,107	6,762	6,164	5,613	5,589	5,255	4,981	4,586	4,212
Operating Cost of Revenue	7,519	7,107	6,762	6,164	5,613	5,589	5,255	4,981	4,586	4,212
Total Operating Expenses	6,627	5,999	5,634	5,115	4,587	4,573	4,342	4,149	3,899	3,572
Selling, General & Admin Expense	5,896	5,290	4,920	4,463	3,961	3,975	3,783	3,598	3,391	3,094
Depreciation Expense	585	568	582	533	510	490	453	448	417	399
Other Operating Expenses / (Income)	146	141	132	119	116	108	106	103	92	79
Total Other Income / (Expense), net	-184	-235	-137	-70	-106	-150	-141	-145	-125	-113
Interest Expense	186	207	127	84	106	163	155	145	125	113
Other Income / (Expense), net	2.23	-28	-10	14	0.01	13	14	0.00	0.00	-
Income Tax Expense	335	221	209	306	299	239	237	364	409	395
Net Income / (Loss) Attributable to Noncontrolling Interest	21	1.51	-19	-3.96	8.84	13	18	19	45	70
Basic Earnings per Share	$17.16	$10.35	$9.23	$11.99	$11.06	$9.16	$8.35	$7.86	$7.22	$6.89
Weighted Average Basic Shares Outstanding	66.55M	69.32M	73.12M	82.52M	85.06M	88.76M	93.28M	95.65M	97.21M	98.80M
Diluted Earnings per Share	$16.82	$10.23	$9.14	$11.82	$10.99	$9.13	$8.31	$7.81	$7.14	$6.76
Weighted Average Diluted Shares Outstanding	67.90M	70.13M	73.83M	83.69M	85.59M	89.04M	93.75M	96.33M	98.38M	100.69M
Weighted Average Basic & Diluted Shares Outstanding	65.00M	67.22M	70.67M	74.81M	85.09M	86.73M	93.40M	95.70M	97.30M	98.80M
Cash Dividends to Common per Share	$0.80	$0.80	$0.80	$0.80	-	$0.60	$0.40	-	-	-

This table shows Universal Health Services' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	317	332	259	289	262	216	167	171	163	175	183
Consolidated Net Income / (Loss)	322	337	266	294	266	220	168	169	162	170	177
Net Income / (Loss) Continuing Operations	322	337	266	294	266	220	168	169	162	170	177
Total Pre-Tax Income	420	438	342	382	336	281	221	225	214	222	234
Total Operating Income	455	472	384	436	389	331	285	280	279	261	276
Total Gross Profit	2,149	2,206	2,051	2,051	2,001	1,905	1,778	1,778	1,714	1,746	1,659
Total Revenue	4,100	4,114	3,963	3,908	3,844	3,704	3,563	3,548	3,468	3,447	3,336
Operating Revenue	4,100	4,114	3,963	3,908	3,844	3,704	3,563	3,548	3,468	3,447	3,336
Total Cost of Revenue	1,951	1,907	1,912	1,856	1,843	1,799	1,785	1,770	1,753	1,701	1,677
Operating Cost of Revenue	1,951	1,907	1,912	1,856	1,843	1,799	1,785	1,770	1,753	1,701	1,677
Total Operating Expenses	1,694	1,734	1,667	1,615	1,612	1,573	1,493	1,498	1,435	1,485	1,383
Selling, General & Admin Expense	1,509	1,549	1,480	1,431	1,436	1,393	1,320	1,319	1,259	1,302	1,204
Depreciation Expense	148	147	150	147	141	145	137	144	142	148	146
Other Operating Expenses / (Income)	37	38	37	36	35	35	35	35	35	35	33
Total Other Income / (Expense), net	-34	-34	-43	-54	-53	-50	-65	-55	-65	-39	-42
Interest Expense	40	40	45	49	53	54	53	49	51	44	36
Other Income / (Expense), net	5.66	5.55	2.03	-5.49	0.15	3.52	-11	-6.60	-14	4.84	-6.02
Income Tax Expense	99	101	76	88	70	62	52	55	52	52	57
Net Income / (Loss) Attributable to Noncontrolling Interest	4.95	4.65	7.20	5.18	3.99	3.24	1.02	-2.01	-0.74	-4.45	-6.00
Basic Earnings per Share	$4.87	$5.05	$3.89	$4.32	$3.90	$3.18	$2.42	$2.44	$2.31	$2.44	$2.52
Weighted Average Basic Shares Outstanding	64.97M	66.55M	66.54M	66.88M	67.20M	69.32M	68.87M	70.07M	70.54M	73.12M	72.60M
Diluted Earnings per Share	$4.80	$4.94	$3.80	$4.26	$3.82	$3.13	$2.40	$2.42	$2.28	$2.42	$2.50
Weighted Average Diluted Shares Outstanding	66.04M	67.90M	68.11M	67.92M	68.48M	70.13M	69.62M	70.84M	71.49M	73.83M	73.06M
Weighted Average Basic & Diluted Shares Outstanding	64.44M	65.00M	65.97M	66.71M	66.93M	67.22M	68.26M	69.39M	70.18M	70.67M	71.41M
Cash Dividends to Common per Share	$0.20	-	$0.20	$0.20	$0.20	-	$0.20	$0.20	$0.20	-	$0.20

This table details how cash moves in and out of Universal Health Services' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Change in Cash & Equivalents	10	14	22	-1,100	1,173	-94	32	45	4.67	29
Net Cash From Operating Activities	2,067	1,268	996	884	2,360	1,438	1,275	1,248	1,334	1,068
Net Cash From Continuing Operating Activities	2,067	1,268	996	884	2,360	1,438	1,275	1,248	1,334	1,068
Net Income / (Loss) Continuing Operations	1,163	719	657	988	953	828	798	771	747	751
Consolidated Net Income / (Loss)	1,163	719	657	988	953	828	798	771	747	751
Depreciation Expense	585	568	582	533	510	490	453	448	417	399
Non-Cash Adjustments To Reconcile Net Income	93	81	144	100	69	160	116	57	93	84
Changes in Operating Assets and Liabilities, net	227	-101	-386	-737	828	-39	-92	-28	77	-165
Net Cash From Investing Activities	-911	-763	-647	-914	-803	-688	-747	-685	-1,155	-913
Net Cash From Continuing Investing Activities	-911	-763	-647	-914	-803	-688	-747	-685	-1,155	-913
Purchase of Property, Plant & Equipment	-944	-743	-734	-856	-731	-634	-665	-558	-541	-379
Acquisitions	-19	-3.73	-20	-105	-52	-8.01	-110	-23	-614	-534
Purchase of Investments	13	-41	95	1.36	-24	-34	-15	-72	-	-
Divestitures	39	24	12	25	8.17	9.45	14	0.11	0.00	3.39
Other Investing Activities, net	0.28	0.02	0.10	20	-3.00	-21	-36	-32	0.00	-3.30
Net Cash From Financing Activities	-1,145	-494	-318	-1,069	-385	-845	-492	-519	-171	-125
Net Cash From Continuing Financing Activities	-1,145	-494	-318	-1,069	-385	-845	-492	-519	-171	-125
Repayment of Debt	-2,653	-86	-93	-3,057	-973	-57	-844	-143	-472	-69
Repurchase of Common Equity	-671	-547	-833	-1,221	-207	-771	-397	-364	-353	-210
Payment of Dividends	-47	-60	-112	-60	-19	-69	-52	-63	-108	-102
Issuance of Debt	2,210	185	705	3,255	802	39	791	41	1,171	234
Issuance of Common Equity	15	14	14	13	12	12	10	10	9.50	8.44
Effect of Exchange Rate Changes	-0.83	3.06	-8.42	-0.50	0.74	-	-2.91	-	-	-1.61
Cash Interest Paid	168	200	120	76	113	157	150	136	107	107
Cash Income Taxes Paid	325	258	251	363	286	261	294	371	345	381

This table details how cash moves in and out of Universal Health Services' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	-1.03	20	-19	17	-7.67	34	1.33	-30	8.20	35	-37
Net Cash From Operating Activities	360	658	333	679	396	452	162	363	291	297	221
Net Cash From Continuing Operating Activities	360	658	333	679	396	452	162	363	291	297	221
Net Income / (Loss) Continuing Operations	322	337	266	294	266	220	168	169	162	170	177
Consolidated Net Income / (Loss)	322	337	266	294	266	220	168	169	162	170	177
Depreciation Expense	148	147	150	147	141	145	137	144	142	148	146
Non-Cash Adjustments To Reconcile Net Income	22	22	28	27	16	22	23	16	21	80	21
Changes in Operating Assets and Liabilities, net	-132	153	-111	211	-26	65	-166	34	-34	-102	-123
Net Cash From Investing Activities	-271	-208	-266	-243	-195	-239	-176	-170	-178	-248	-73
Net Cash From Continuing Investing Activities	-271	-208	-266	-243	-195	-239	-176	-170	-178	-248	-73
Purchase of Property, Plant & Equipment	-239	-246	-248	-241	-209	-206	-200	-168	-169	-164	-162
Acquisitions	-8.31	-19	-	-	0.00	-	-	-3.73	0.00	-1.64	-6.18
Purchase of Investments	-24	49	-42	-1.49	8.32	-33	24	-12	-19	-82	93
Divestitures	0.00	8.34	25	-	5.43	0.50	-	14	9.26	-	1.77
Other Investing Activities, net	-0.26	0.08	0.00	0.04	0.16	0.02	-	-	0.00	-	-
Net Cash From Financing Activities	-91	-427	-90	-420	-209	-182	18	-224	-106	-15	-179
Net Cash From Continuing Financing Activities	-91	-427	-90	-420	-209	-182	18	-224	-106	-15	-179
Repayment of Debt	-9.11	-171	-2,099	-319	-64	-31	40	-77	-17	104	33
Repurchase of Common Equity	-223	-250	-183	-96	-142	-162	-176	-125	-85	-110	-158
Payment of Dividends	-15	-9.74	-10	-8.83	-18	-13	-14	-14	-18	-14	-62
Issuance of Debt	152	-	2,198	-	12	20	165	-11	11	-	5.32
Issuance of Common Equity	3.66	4.21	3.64	3.99	3.24	3.81	3.24	3.61	2.99	3.67	3.74
Other Net Changes in Cash	1.65	-	-	-	-0.49	-	-	-	1.65	-	-
Cash Interest Paid	28	24	48	48	48	51	52	47	50	41	35
Cash Income Taxes Paid	5.64	88	105	129	2.67	67	57	131	2.36	69	37

This table presents Universal Health Services' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Total Assets	14,470	13,968	13,494	13,094	13,477	11,668	11,265	10,762	10,318	9,615
Total Current Assets	2,816	2,811	2,537	2,264	3,282	1,916	1,938	1,798	1,681	1,718
Cash & Equivalents	126	119	103	115	1,224	61	105	74	34	61
Accounts Receivable	2,178	2,238	2,018	1,747	1,729	1,561	1,510	1,501	1,440	1,302
Inventories, net	221	217	219	207	190	160	148	136	125	116
Other Current Assets	292	237	198	195	138	134	174	87	83	103
Plant, Property, & Equipment, net	6,572	6,125	5,918	5,874	5,373	5,017	4,848	4,572	4,331	3,836
Plant, Property & Equipment, gross	12,643	11,777	11,086	10,771	9,886	9,106	8,519	7,921	7,314	6,531
Accumulated Depreciation	6,071	5,653	5,167	4,896	4,513	4,090	3,716	3,349	2,983	2,695
Total Noncurrent Assets	5,081	5,032	5,038	4,956	4,822	4,736	4,474	4,392	4,305	11,766
Goodwill	3,933	3,932	3,909	3,963	3,883	3,870	3,845	3,825	3,784	3,596
Noncurrent Deferred & Refundable Income Taxes	118	86	68	46	23	16	-	3.01	1.23	0.00
Other Noncurrent Operating Assets	1,030	580	1,061	947	916	850	630	564	520	8,170
Total Liabilities & Shareholders' Equity	14,470	13,968	13,494	13,094	13,477	11,668	11,265	10,762	10,318	9,615
Total Liabilities	7,707	7,766	7,524	6,895	7,070	6,085	5,795	5,704	5,711	5,064
Total Current Liabilities	2,210	2,013	1,914	1,984	2,481	1,563	1,449	1,848	1,317	1,100
Short-Term Debt	40	127	81	48	332	88	63	546	106	63
Accounts Payable	632	614	637	659	571	447	446	442	440	366
Accrued Expenses	635	473	524	560	526	354	389	389	403	349
Current Deferred Revenue	0.00	5.38	2.40	0.01	376	0.00	-	-	-	-
Current Deferred & Payable Income Tax Liabilities	14	2.05	4.61	11	44	2.52	2.43	18	2.15	3.99
Current Employee Benefit Liabilities	623	549	471	466	410	380	343	305	275	245
Other Taxes Payable	162	154	111	161	152	72	56	86	68	60
Other Current Liabilities	75	72	68	64	60	201	129	39	-	-
Other Current Nonoperating Liabilities	30	17	16	14	9.46	19	19	24	23	13
Total Noncurrent Liabilities	5,497	5,752	5,610	4,911	4,589	4,522	4,347	3,856	4,394	3,963
Long-Term Debt	4,464	4,786	4,727	4,142	3,524	3,897	3,935	3,494	4,030	3,369
Capital Lease Obligations	376	-	396	-	601	270	-	-	-	-
Other Noncurrent Operating Liabilities	656	967	488	769	459	330	362	306	275	279
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	13	5.19	4.70	5.12	4.57	4.33	4.29	6.70	9.32	243
Total Equity & Noncontrolling Interests	6,750	6,197	5,965	6,193	6,402	5,579	5,466	5,051	4,598	4,309
Total Preferred & Common Equity	6,666	6,149	5,921	6,090	6,317	5,503	5,389	4,990	4,533	4,250
Total Common Equity	6,666	6,149	5,921	6,090	6,317	5,503	5,389	4,990	4,533	4,250
Common Stock	0.65	0.67	0.71	0.77	0.85	0.00	0.91	0.94	0.97	0.98
Retained Earnings	6,658	6,139	5,930	6,604	6,268	5,471	5,384	4,981	4,558	4,272
Accumulated Other Comprehensive Income / (Loss)	7.20	9.29	-9.67	30	48	32	4.24	7.18	-25	-23
Noncontrolling Interest	83	48	45	103	85	75	77	62	64	60

This table presents Universal Health Services' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Total Assets	14,875	14,470	14,354	14,071	14,046	13,968	13,873	13,732	13,556	13,494	13,379
Total Current Assets	3,077	2,816	2,802	2,741	2,871	2,811	2,753	2,625	2,559	2,537	2,457
Cash & Equivalents	127	126	106	129	112	119	81	79	110	103	75
Accounts Receivable	2,412	2,178	2,214	2,157	2,299	2,238	2,234	2,103	2,032	2,018	1,902
Inventories, net	222	221	220	219	216	217	215	215	216	219	218
Other Current Assets	317	292	262	236	243	237	223	226	201	198	262
Plant, Property, & Equipment, net	6,697	6,572	6,443	6,335	6,185	6,125	6,087	6,028	5,954	5,918	5,936
Plant, Property & Equipment, gross	12,905	12,643	12,448	12,240	11,955	11,777	11,610	11,442	11,251	11,086	11,104
Accumulated Depreciation	6,209	6,071	6,006	5,905	5,770	5,653	5,523	5,414	5,297	5,167	5,167
Total Noncurrent Assets	5,101	5,081	5,109	4,996	4,990	5,032	5,033	5,080	5,043	5,038	4,986
Goodwill	3,948	3,933	3,965	3,942	3,928	3,932	3,912	3,930	3,914	3,909	3,874
Noncurrent Deferred & Refundable Income Taxes	133	118	122	108	95	86	100	110	91	68	56
Other Noncurrent Operating Assets	1,020	1,030	1,022	946	967	580	1,022	1,040	1,038	1,061	1,056
Total Liabilities & Shareholders' Equity	14,875	14,470	14,354	14,071	14,046	13,968	13,873	13,732	13,556	13,494	13,379
Total Liabilities	7,990	7,707	7,667	7,515	7,735	7,766	7,762	7,599	7,499	7,524	7,470
Total Current Liabilities	2,330	2,210	2,011	2,149	2,075	2,013	1,990	2,035	1,863	1,914	1,939
Short-Term Debt	40	40	38	128	127	127	127	111	96	81	66
Accounts Payable	2,092	632	1,896	1,926	1,830	614	1,783	1,843	1,636	637	1,795
Current Deferred & Payable Income Tax Liabilities	121	14	3.80	23	47	2.05	7.15	6.96	58	4.61	7.74
Other Current Liabilities	76	75	73	72	71	72	73	74	73	68	70
Total Noncurrent Liabilities	5,659	5,497	5,656	5,366	5,660	5,752	5,772	5,564	5,636	5,610	5,531
Long-Term Debt	4,609	4,464	4,618	4,417	4,734	4,786	4,796	4,605	4,707	4,727	4,638
Capital Lease Obligations	369	376	378	380	374	-	389	388	396	396	393
Other Noncurrent Operating Liabilities	682	656	660	570	551	967	588	571	532	488	500
Redeemable Noncontrolling Interest	13	13	5.62	5.42	4.99	5.19	4.72	4.21	4.27	4.70	4.56
Total Equity & Noncontrolling Interests	6,872	6,750	6,681	6,551	6,306	6,197	6,106	6,129	6,052	5,965	5,904
Total Preferred & Common Equity	6,786	6,666	6,606	6,485	6,257	6,149	6,065	6,087	0.00	5,921	5,855
Total Common Equity	6,786	6,666	6,606	6,485	6,257	6,149	6,065	6,087	0.00	5,921	5,855
Common Stock	6,786	0.65	6,606	6,485	6,257	0.67	6,065	6,087	-	0.71	5,855
Noncontrolling Interest	87	83	75	65	49	48	42	42	6,052	45	49

This table displays calculated financial ratios and metrics derived from Universal Health Services' official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	10.82%	6.59%	5.99%	9.37%	1.59%	5.63%	3.48%	6.59%	7.99%	10.22%
EBITDA Growth	32.29%	8.90%	-17.55%	2.21%	8.69%	4.68%	-4.95%	1.77%	2.41%	15.23%
EBIT Growth	46.81%	15.50%	-27.88%	1.37%	10.52%	3.33%	-7.08%	-0.10%	1.75%	18.44%
NOPAT Growth	45.26%	18.12%	-26.88%	0.70%	9.54%	4.10%	4.19%	5.07%	0.35%	19.23%
Net Income Growth	61.70%	9.49%	-33.48%	3.66%	15.13%	3.72%	3.44%	3.23%	-0.47%	24.08%
EPS Growth	64.42%	11.93%	-22.67%	7.55%	20.37%	9.87%	6.40%	9.38%	5.62%	24.72%
Operating Cash Flow Growth	63.05%	27.29%	12.71%	-62.56%	64.08%	12.84%	2.18%	-6.47%	24.86%	3.13%
Free Cash Flow Firm Growth	-20.87%	2,642.29%	-109.53%	-65.95%	124.67%	-8.83%	3.89%	-92.83%	2,652.50%	1.34%
Invested Capital Growth	4.86%	-0.67%	7.77%	6.62%	-1.50%	4.46%	3.65%	3.61%	-44.17%	7.77%
Revenue Q/Q Growth	2.66%	1.83%	1.30%	1.51%	1.68%	1.26%	1.05%	1.63%	3.34%	-0.17%
EBITDA Q/Q Growth	6.81%	3.98%	-2.76%	-4.83%	3.79%	7.68%	-3.55%	1.82%	-0.18%	0.26%
EBIT Q/Q Growth	9.30%	6.35%	-5.67%	-6.54%	4.78%	10.12%	-5.16%	1.95%	-0.59%	-0.04%
NOPAT Q/Q Growth	8.69%	6.99%	-4.89%	-6.92%	5.43%	6.60%	-5.04%	6.49%	-1.23%	-0.11%
Net Income Q/Q Growth	11.23%	7.35%	-8.82%	-6.95%	6.69%	11.36%	-7.15%	6.39%	-1.66%	0.11%
EPS Q/Q Growth	12.06%	7.46%	-5.97%	-4.68%	7.64%	13.42%	-6.63%	7.28%	0.42%	0.60%
Operating Cash Flow Q/Q Growth	11.07%	13.94%	-2.42%	25.58%	-7.50%	0.56%	-3.30%	15.94%	-5.29%	-6.52%
Free Cash Flow Firm Q/Q Growth	-17.02%	126.45%	80.25%	15,366.04%	-34.07%	-18.10%	20.49%	1,204.47%	2,542.46%	-148.06%
Invested Capital Q/Q Growth	-0.58%	-2.90%	1.42%	3.53%	9.38%	1.70%	-0.11%	1.52%	8.55%	108.56%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	52.50%	50.23%	49.53%	51.24%	51.44%	50.88%	51.22%	52.15%	53.05%	53.42%
EBITDA Margin	14.33%	12.01%	11.75%	15.11%	16.17%	15.11%	15.25%	16.60%	17.39%	18.33%
Operating Margin	10.63%	8.23%	7.49%	10.78%	11.75%	10.69%	10.91%	12.30%	13.12%	13.93%
EBIT Margin	10.64%	8.03%	7.41%	10.89%	11.75%	10.80%	11.04%	12.30%	13.12%	13.93%
Profit (Net Income) Margin	7.35%	5.04%	4.90%	7.81%	8.24%	7.27%	7.41%	7.41%	7.65%	8.30%
Tax Burden Percent	77.65%	76.49%	75.84%	76.36%	76.10%	77.61%	77.13%	67.96%	64.61%	65.51%
Interest Burden Percent	88.95%	81.98%	87.22%	93.92%	92.18%	86.76%	86.97%	88.66%	90.24%	90.99%
Effective Tax Rate	22.35%	23.51%	24.16%	23.64%	23.90%	22.39%	22.87%	32.04%	35.39%	34.49%
Return on Invested Capital (ROIC)	11.58%	8.14%	7.12%	10.44%	10.63%	9.84%	9.84%	9.79%	6.79%	5.47%
ROIC Less NNEP Spread (ROIC-NNEP)	8.60%	4.52%	4.86%	8.99%	8.46%	6.98%	7.09%	7.35%	5.73%	4.78%
Return on Net Nonoperating Assets (RNNOA)	6.37%	3.68%	3.68%	5.23%	5.26%	5.13%	5.32%	6.17%	9.52%	12.02%
Return on Equity (ROE)	17.94%	11.82%	10.80%	15.67%	15.89%	14.97%	15.16%	15.96%	16.32%	17.49%
Cash Return on Invested Capital (CROIC)	6.83%	8.81%	-0.36%	4.03%	12.14%	5.48%	6.26%	6.24%	63.48%	-2.01%
Operating Return on Assets (OROA)	11.84%	8.35%	7.47%	10.36%	10.80%	10.72%	10.80%	12.15%	12.86%	13.55%
Return on Assets (ROA)	8.18%	5.24%	4.94%	7.43%	7.58%	7.22%	7.24%	7.32%	7.50%	8.08%
Return on Common Equity (ROCE)	17.74%	11.72%	10.66%	15.42%	15.67%	14.76%	14.94%	15.73%	15.65%	16.28%
Return on Equity Simple (ROE_SIMPLE)	17.45%	11.70%	11.10%	16.22%	15.08%	15.04%	14.81%	15.46%	16.48%	17.66%
Net Operating Profit after Tax (NOPAT)	1,306	899	761	1,041	1,034	944	906	870	828	825
NOPAT Margin	8.25%	6.29%	5.68%	8.23%	8.94%	8.29%	8.41%	8.36%	8.48%	9.12%
Net Nonoperating Expense Percent (NNEP)	2.98%	3.62%	2.26%	1.45%	2.17%	2.86%	2.75%	2.43%	1.06%	0.69%
Return On Investment Capital (ROIC_SIMPLE)	11.23%	8.09%	6.81%	-	-	-	-	-	-	-
Cost of Revenue to Revenue	47.50%	49.77%	50.47%	48.76%	48.56%	49.12%	48.78%	47.85%	46.95%	46.58%
SG&A Expenses to Revenue	37.25%	37.04%	36.72%	35.30%	34.27%	34.94%	35.12%	34.56%	34.72%	34.21%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	41.87%	42.00%	42.04%	40.46%	39.69%	40.19%	40.31%	39.86%	39.93%	39.49%
Earnings before Interest and Taxes (EBIT)	1,684	1,147	993	1,377	1,358	1,229	1,189	1,280	1,281	1,259
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	2,269	1,715	1,575	1,910	1,869	1,719	1,643	1,728	1,698	1,658
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.78	1.69	1.68	1.69	1.81	2.23	1.95	2.09	2.20	2.67
Price to Tangible Book Value (P/TBV)	4.33	4.68	4.95	4.83	4.70	7.53	6.80	8.97	13.32	17.36
Price to Revenue (P/Rev)	0.75	0.73	0.74	0.81	0.99	1.08	0.98	1.00	1.02	1.25
Price to Earnings (P/E)	10.36	14.44	14.74	10.36	12.13	15.09	13.47	13.88	14.21	16.67
Dividend Yield	0.45%	0.53%	0.57%	0.63%	0.52%	0.43%	0.35%	0.36%	0.39%	0.35%
Earnings Yield	9.65%	6.93%	6.78%	9.66%	8.24%	6.63%	7.42%	7.20%	7.04%	6.00%
Enterprise Value to Invested Capital (EV/IC)	1.45	1.38	1.36	1.40	1.53	1.69	1.54	1.60	1.62	0.96
Enterprise Value to Revenue (EV/Rev)	1.05	1.06	1.13	1.14	1.28	1.46	1.34	1.39	1.45	1.66
Enterprise Value to EBITDA (EV/EBITDA)	7.35	8.87	9.59	7.57	7.90	9.63	8.81	8.38	8.34	9.06
Enterprise Value to EBIT (EV/EBIT)	9.91	13.26	15.22	10.50	10.87	13.48	12.17	11.31	11.05	11.93
Enterprise Value to NOPAT (EV/NOPAT)	12.78	16.92	19.85	13.89	14.29	17.55	15.97	16.64	17.10	18.20
Enterprise Value to Operating Cash Flow (EV/OCF)	8.07	12.00	15.17	16.36	6.26	11.52	11.36	11.61	10.61	14.06
Enterprise Value to Free Cash Flow (EV/FCFF)	21.66	15.62	0.00	35.95	12.51	31.52	25.12	26.10	1.83	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.72	0.79	0.87	0.68	0.70	0.76	0.73	0.80	0.90	0.75
Long-Term Debt to Equity	0.72	0.77	0.86	0.67	0.64	0.75	0.72	0.69	0.87	0.74
Financial Leverage	0.74	0.82	0.76	0.58	0.62	0.73	0.75	0.84	1.66	2.51
Leverage Ratio	2.19	2.26	2.19	2.11	2.10	2.07	2.09	2.18	2.18	2.17
Compound Leverage Factor	1.95	1.85	1.91	1.98	1.93	1.80	1.82	1.93	1.96	1.97
Debt to Total Capital	41.92%	44.20%	46.57%	40.34%	41.03%	43.25%	42.23%	44.40%	47.31%	42.98%
Short-Term Debt to Total Capital	0.34%	1.14%	0.73%	0.47%	3.06%	0.89%	0.67%	6.00%	1.21%	0.79%
Long-Term Debt to Total Capital	41.57%	43.06%	45.84%	39.87%	37.97%	42.36%	41.56%	38.41%	46.10%	42.20%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.83%	0.48%	0.44%	1.04%	0.82%	0.80%	0.85%	0.75%	0.84%	3.78%
Common Equity to Total Capital	57.25%	55.32%	52.99%	58.62%	58.15%	55.94%	56.92%	54.84%	51.85%	53.23%
Debt to EBITDA	2.15	2.86	3.30	2.19	2.39	2.47	2.43	2.34	2.44	2.07
Net Debt to EBITDA	2.10	2.79	3.24	2.13	1.73	2.44	2.37	2.29	2.42	2.03
Long-Term Debt to EBITDA	2.13	2.79	3.25	2.17	2.21	2.42	2.40	2.02	2.37	2.03
Debt to NOPAT	3.74	5.46	6.84	4.03	4.31	4.51	4.41	4.64	5.00	4.16
Net Debt to NOPAT	3.64	5.33	6.70	3.91	3.13	4.44	4.30	4.56	4.95	4.08
Long-Term Debt to NOPAT	3.71	5.32	6.73	3.98	3.99	4.42	4.34	4.02	4.87	4.08
Altman Z-Score	3.09	2.78	2.70	2.94	2.88	3.23	3.11	3.10	3.07	3.42
Noncontrolling Interest Sharing Ratio	1.15%	0.84%	1.30%	1.57%	1.41%	1.45%	1.42%	1.47%	4.10%	6.95%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.27	1.40	1.33	1.14	1.32	1.23	1.34	0.97	1.28	1.56
Quick Ratio	1.04	1.17	1.11	0.94	1.19	1.04	1.11	0.85	1.12	1.24
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	770	974	-38	402	1,181	525	576	555	7,736	-303
Operating Cash Flow to CapEx	219.02%	170.62%	135.70%	103.28%	322.73%	226.85%	191.70%	223.78%	246.36%	281.62%
Free Cash Flow to Firm to Interest Expense	4.14	4.71	-0.30	4.80	11.11	3.23	3.72	3.82	61.86	-2.67
Operating Cash Flow to Interest Expense	11.11	6.13	7.85	10.56	22.21	8.84	8.23	8.59	10.67	9.41
Operating Cash Flow Less CapEx to Interest Expense	6.04	2.54	2.07	0.34	15.33	4.94	3.94	4.75	6.34	6.07
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.11	1.04	1.01	0.95	0.92	0.99	0.98	0.99	0.98	0.97
Accounts Receivable Turnover	7.17	6.71	7.12	7.27	7.03	7.41	7.16	7.08	7.12	7.00
Inventory Turnover	34.34	32.64	31.80	31.03	32.05	36.28	36.95	38.09	37.99	37.59
Fixed Asset Turnover	2.49	2.37	2.27	2.25	2.23	2.31	2.29	2.34	2.39	2.41
Accounts Payable Turnover	12.07	11.37	10.44	10.03	11.03	12.52	11.84	11.30	11.38	11.99
Days Sales Outstanding (DSO)	50.92	54.38	51.27	50.17	51.94	49.25	51.01	51.55	51.24	52.17
Days Inventory Outstanding (DIO)	10.63	11.18	11.48	11.76	11.39	10.06	9.88	9.58	9.61	9.71
Days Payable Outstanding (DPO)	30.24	32.11	34.96	36.40	33.08	29.15	30.83	32.31	32.07	30.44
Cash Conversion Cycle (CCC)	31.30	33.46	27.79	25.53	30.25	30.17	30.06	28.83	28.77	31.44
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	11,548	11,012	11,087	10,288	9,649	9,796	9,377	9,047	8,732	15,640
Invested Capital Turnover	1.40	1.29	1.25	1.27	1.19	1.19	1.17	1.17	0.80	0.60
Increase / (Decrease) in Invested Capital	535	-75	799	639	-147	418	330	315	-6,908	1,128
Enterprise Value (EV)	16,687	15,208	15,111	14,453	14,772	16,564	14,477	14,480	14,154	15,019
Market Capitalization	11,836	10,362	9,961	10,270	11,449	12,292	10,503	10,445	9,978	11,347
Book Value per Share	$101.06	$90.08	$82.91	$75.76	$74.34	$62.84	$58.25	$52.57	$46.76	$43.16
Tangible Book Value per Share	$41.44	$32.47	$28.16	$26.46	$28.65	$18.65	$16.70	$12.27	$7.73	$6.64
Total Capital	11,644	11,114	11,174	10,388	10,864	9,837	9,469	9,098	8,743	7,983
Total Debt	4,881	4,912	5,204	4,190	4,457	4,254	3,999	4,040	4,136	3,431
Total Long-Term Debt	4,841	4,786	5,122	4,142	4,125	4,167	3,935	3,494	4,030	3,369
Net Debt	4,755	4,793	5,101	4,075	3,233	4,193	3,893	3,966	4,102	3,370
Capital Expenditures (CapEx)	944	743	734	856	731	634	665	558	541	379
Debt-free, Cash-free Net Working Capital (DFCFNWC)	520	805	602	213	-92	379	447	421	436	619
Debt-free Net Working Capital (DFNWC)	646	925	704	328	1,133	440	553	496	470	681
Net Working Capital (NWC)	606	798	623	279	801	353	489	-50	364	618
Net Nonoperating Expense (NNE)	143	180	104	53	81	116	109	99	81	74
Net Nonoperating Obligations (NNO)	4,785	4,810	5,117	4,089	3,242	4,212	3,907	3,989	4,125	11,088
Total Depreciation and Amortization (D&A)	585	568	582	533	510	490	453	448	417	399
Debt-free, Cash-free Net Working Capital to Revenue	3.29%	5.64%	4.49%	1.68%	-0.79%	3.33%	4.15%	4.05%	4.47%	6.85%
Debt-free Net Working Capital to Revenue	4.08%	6.47%	5.26%	2.59%	9.80%	3.87%	5.13%	4.76%	4.81%	7.53%
Net Working Capital to Revenue	3.83%	5.59%	4.65%	2.21%	6.93%	3.10%	4.54%	-0.48%	3.73%	6.83%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$17.16	$10.35	$9.23	$11.99	$11.06	$9.16	$8.35	$7.86	$7.22	$6.89
Adjusted Weighted Average Basic Shares Outstanding	66.55M	69.32M	73.12M	82.52M	85.06M	88.76M	93.28M	95.65M	97.21M	98.80M
Adjusted Diluted Earnings per Share	$16.82	$10.23	$9.14	$11.82	$10.99	$9.13	$8.31	$7.81	$7.14	$6.76
Adjusted Weighted Average Diluted Shares Outstanding	67.90M	70.13M	73.83M	83.69M	85.59M	89.04M	93.75M	96.33M	98.38M	100.69M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	65.00M	67.22M	70.67M	74.81M	85.09M	86.73M	90.78M	94.27M	96.60M	97.67M
Normalized Net Operating Profit after Tax (NOPAT)	1,306	899	761	1,041	1,034	944	906	870	828	825
Normalized NOPAT Margin	8.25%	6.29%	5.68%	8.23%	8.94%	8.29%	8.41%	8.36%	8.48%	9.12%
Pre Tax Income Margin	9.46%	6.58%	6.46%	10.23%	10.83%	9.37%	9.60%	10.90%	11.84%	12.67%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	9.05	5.55	7.83	16.46	12.78	7.55	7.68	8.82	10.25	11.10
NOPAT to Interest Expense	7.02	4.35	6.00	12.44	9.73	5.80	5.85	5.99	6.62	7.27
EBIT Less CapEx to Interest Expense	3.98	1.96	2.04	6.23	5.90	3.66	3.39	4.98	5.92	7.75
NOPAT Less CapEx to Interest Expense	1.95	0.75	0.21	2.21	2.84	1.90	1.56	2.15	2.29	3.93
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	4.03%	8.28%	17.10%	6.05%	2.01%	8.32%	6.51%	8.16%	14.52%	13.55%
Augmented Payout Ratio	61.70%	84.37%	143.88%	129.67%	23.71%	101.43%	56.32%	55.40%	61.81%	41.50%

This table displays calculated financial ratios and metrics derived from Universal Health Services' official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	6.66%	11.08%	11.23%	10.13%	10.85%	7.44%	6.80%	6.76%	5.30%	5.24%	5.70%
EBITDA Growth	14.89%	30.12%	30.33%	38.61%	30.33%	15.83%	-1.12%	10.02%	11.26%	-9.74%	-6.06%
EBIT Growth	18.40%	42.82%	41.01%	57.54%	46.77%	25.73%	1.49%	16.19%	19.54%	-18.33%	-12.41%
NOPAT Growth	13.16%	40.42%	37.57%	59.30%	45.47%	29.18%	4.39%	19.43%	20.20%	-16.26%	-13.48%
Net Income Growth	20.99%	53.47%	58.27%	73.85%	63.71%	28.91%	-4.98%	6.63%	7.52%	-27.17%	-19.40%
EPS Growth	25.65%	57.83%	58.33%	76.03%	67.54%	29.34%	-4.00%	10.00%	12.87%	-19.33%	-3.85%
Operating Cash Flow Growth	-9.17%	45.53%	105.97%	87.16%	36.34%	52.18%	-26.74%	1,012.86%	-34.73%	-7.68%	-50.10%
Free Cash Flow Firm Growth	-70.59%	-151.65%	113.49%	169.49%	104.11%	155.64%	75.46%	65.40%	43.75%	-49.88%	10.19%
Invested Capital Growth	2.99%	4.86%	2.41%	1.74%	2.59%	-0.67%	3.75%	3.88%	6.51%	7.77%	10.00%
Revenue Q/Q Growth	-0.34%	3.80%	1.42%	1.67%	3.78%	3.95%	0.41%	2.33%	0.60%	3.33%	0.38%
EBITDA Q/Q Growth	-2.56%	16.62%	-7.37%	9.15%	10.35%	16.81%	-1.48%	2.62%	-1.92%	-0.28%	9.62%
EBIT Q/Q Growth	-3.67%	23.78%	-10.38%	10.80%	16.19%	22.21%	0.13%	3.23%	-0.47%	-1.35%	14.64%
NOPAT Q/Q Growth	-4.24%	21.47%	-11.04%	9.35%	18.84%	19.01%	3.01%	-0.14%	5.53%	-3.83%	17.85%
Net Income Q/Q Growth	-4.57%	26.75%	-9.66%	10.72%	21.04%	30.72%	-0.76%	4.27%	-4.69%	-3.64%	11.36%
EPS Q/Q Growth	-2.83%	30.00%	-10.80%	11.52%	22.04%	30.42%	-0.83%	6.14%	-5.79%	-3.20%	13.64%
Operating Cash Flow Q/Q Growth	-45.32%	97.74%	-50.98%	71.36%	-12.38%	179.86%	-55.46%	24.83%	-2.20%	34.73%	576.62%
Free Cash Flow Firm Q/Q Growth	103.30%	-761.44%	-81.75%	638.20%	160.80%	272.82%	6.04%	56.29%	21.60%	23.76%	-32.46%
Invested Capital Q/Q Growth	1.99%	-0.58%	2.32%	-0.73%	0.50%	-2.90%	1.65%	0.10%	0.54%	1.42%	1.77%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	52.41%	53.63%	51.75%	52.49%	52.06%	51.42%	49.90%	50.11%	49.44%	50.65%	49.72%
EBITDA Margin	14.85%	15.19%	13.52%	14.80%	13.79%	12.97%	11.54%	11.76%	11.73%	12.03%	12.46%
Operating Margin	11.09%	11.49%	9.69%	11.17%	10.11%	8.94%	8.01%	7.90%	8.04%	7.58%	8.27%
EBIT Margin	11.23%	11.62%	9.74%	11.03%	10.12%	9.04%	7.69%	7.71%	7.64%	7.72%	8.09%
Profit (Net Income) Margin	7.85%	8.19%	6.71%	7.53%	6.92%	5.93%	4.72%	4.77%	4.68%	4.94%	5.30%
Tax Burden Percent	76.50%	76.90%	77.86%	77.05%	79.09%	78.12%	76.19%	75.35%	75.84%	76.63%	75.49%
Interest Burden Percent	91.30%	91.69%	88.44%	88.65%	86.42%	83.99%	80.51%	82.15%	80.80%	83.51%	86.79%
Effective Tax Rate	23.50%	23.10%	22.14%	22.95%	20.91%	21.88%	23.81%	24.65%	24.16%	23.37%	24.51%
Return on Invested Capital (ROIC)	11.76%	12.39%	10.14%	11.48%	10.39%	9.03%	7.69%	7.50%	7.66%	7.29%	7.91%
ROIC Less NNEP Spread (ROIC-NNEP)	11.24%	11.85%	9.48%	10.63%	9.57%	8.24%	6.72%	6.65%	6.64%	6.64%	7.18%
Return on Net Nonoperating Assets (RNNOA)	8.53%	8.77%	7.53%	8.22%	7.90%	6.72%	5.73%	5.44%	5.29%	5.02%	5.02%
Return on Equity (ROE)	20.29%	21.16%	17.67%	19.71%	18.29%	15.75%	13.42%	12.94%	12.95%	12.31%	12.94%
Cash Return on Invested Capital (CROIC)	8.65%	6.83%	8.09%	8.23%	6.26%	8.81%	3.86%	3.79%	1.07%	-0.36%	-1.86%
Operating Return on Assets (OROA)	12.49%	12.94%	10.65%	11.91%	10.75%	9.40%	7.91%	7.87%	7.77%	7.78%	8.16%
Return on Assets (ROA)	8.73%	9.12%	7.33%	8.14%	7.35%	6.17%	4.85%	4.87%	4.76%	4.98%	5.35%
Return on Common Equity (ROCE)	20.05%	20.92%	17.49%	19.53%	9.25%	15.62%	13.31%	12.79%	6.32%	12.15%	6.17%
Return on Equity Simple (ROE_SIMPLE)	17.96%	0.00%	15.83%	14.61%	13.15%	0.00%	11.05%	11.15%	0.00%	0.00%	12.31%
Net Operating Profit after Tax (NOPAT)	348	363	299	336	307	259	217	211	211	200	208
NOPAT Margin	8.49%	8.83%	7.55%	8.60%	8.00%	6.99%	6.10%	5.95%	6.10%	5.81%	6.24%
Net Nonoperating Expense Percent (NNEP)	0.53%	0.55%	0.65%	0.85%	0.82%	0.79%	0.96%	0.85%	1.02%	0.65%	0.73%
Return On Investment Capital (ROIC_SIMPLE)	2.93%	3.12%	-	-	-	2.33%	-	-	-	1.79%	-
Cost of Revenue to Revenue	47.59%	46.37%	48.25%	47.51%	47.94%	48.58%	50.10%	49.89%	50.56%	49.35%	50.28%
SG&A Expenses to Revenue	36.80%	37.65%	37.36%	36.63%	37.35%	37.60%	37.05%	37.16%	36.31%	37.76%	36.08%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	41.31%	42.15%	42.05%	41.33%	41.95%	42.48%	41.89%	42.21%	41.40%	43.07%	41.45%
Earnings before Interest and Taxes (EBIT)	460	478	386	431	389	335	274	274	265	266	270
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	609	625	536	578	530	480	411	417	407	415	416
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.80	1.78	2.31	1.91	1.99	1.69	1.43	1.81	0.00	1.68	1.09
Price to Tangible Book Value (P/TBV)	4.30	4.33	5.79	4.87	5.34	4.68	4.03	5.11	0.00	4.95	3.22
Price to Revenue (P/Rev)	0.76	0.75	0.99	0.82	0.85	0.73	0.62	0.80	0.66	0.74	0.48
Price to Earnings (P/E)	10.20	10.36	14.89	13.25	15.24	14.44	12.84	15.92	13.03	14.74	8.61
Dividend Yield	0.43%	0.45%	0.35%	0.43%	0.44%	0.53%	0.64%	0.51%	0.63%	0.57%	0.92%
Earnings Yield	9.80%	9.65%	6.72%	7.55%	6.56%	6.93%	7.79%	6.28%	7.68%	6.78%	11.61%
Enterprise Value to Invested Capital (EV/IC)	1.46	1.45	1.75	1.52	1.54	1.38	1.23	1.44	1.80	1.36	1.05
Enterprise Value to Revenue (EV/Rev)	1.07	1.05	1.32	1.15	1.20	1.06	1.00	1.17	1.48	1.13	0.87
Enterprise Value to EBITDA (EV/EBITDA)	7.33	7.35	9.55	8.62	9.58	8.87	8.46	9.72	12.42	9.59	7.07
Enterprise Value to EBIT (EV/EBIT)	9.80	9.91	13.17	12.07	13.86	13.26	12.94	14.97	19.36	15.22	10.87
Enterprise Value to NOPAT (EV/NOPAT)	12.78	12.78	16.88	15.39	17.70	16.92	16.62	19.35	25.19	19.85	14.31
Enterprise Value to Operating Cash Flow (EV/OCF)	8.47	8.07	10.90	10.20	12.83	12.00	12.55	13.73	23.85	15.17	11.22
Enterprise Value to Free Cash Flow (EV/FCFF)	17.13	21.66	21.85	18.61	24.91	15.62	32.47	38.79	173.61	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.73	0.72	0.75	0.75	0.83	0.79	0.87	0.83	0.86	0.87	0.86
Long-Term Debt to Equity	0.72	0.72	0.75	0.73	0.81	0.77	0.85	0.81	0.84	0.86	0.85
Financial Leverage	0.76	0.74	0.79	0.77	0.83	0.82	0.85	0.82	0.80	0.76	0.70
Leverage Ratio	2.19	2.19	2.21	2.19	2.23	2.26	2.27	2.24	2.22	2.19	2.14
Compound Leverage Factor	2.00	2.01	1.95	1.94	1.93	1.89	1.83	1.84	1.79	1.82	1.85
Debt to Total Capital	42.16%	41.92%	42.95%	42.89%	45.35%	44.20%	46.50%	45.42%	46.20%	46.57%	46.31%
Short-Term Debt to Total Capital	0.34%	0.34%	0.33%	1.11%	1.10%	1.14%	1.11%	0.99%	0.85%	0.73%	0.60%
Long-Term Debt to Total Capital	41.82%	41.57%	42.62%	41.78%	44.24%	43.06%	45.39%	44.43%	45.34%	45.84%	45.71%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.84%	0.83%	0.69%	0.62%	0.47%	0.48%	0.41%	0.41%	53.81%	0.44%	0.48%
Common Equity to Total Capital	57.00%	57.25%	56.36%	56.49%	54.18%	55.32%	53.10%	54.17%	0.00%	52.99%	53.20%
Debt to EBITDA	2.14	2.15	2.37	2.46	2.85	2.86	3.22	3.09	3.22	3.30	3.15
Net Debt to EBITDA	2.08	2.10	2.32	2.40	2.79	2.79	3.17	3.04	3.15	3.24	3.10
Long-Term Debt to EBITDA	2.12	2.13	2.35	2.40	2.78	2.79	3.14	3.02	3.16	3.25	3.11
Debt to NOPAT	3.73	3.74	4.19	4.40	5.26	5.46	6.32	6.14	6.53	6.84	6.37
Net Debt to NOPAT	3.63	3.64	4.10	4.28	5.15	5.33	6.22	6.05	6.39	6.70	6.28
Long-Term Debt to NOPAT	3.70	3.71	4.16	4.28	5.13	5.32	6.17	6.01	6.41	6.73	6.29
Altman Z-Score	2.16	2.82	2.42	2.21	2.17	2.59	1.81	1.99	1.84	2.52	1.61
Noncontrolling Interest Sharing Ratio	1.17%	1.15%	0.99%	0.92%	49.41%	0.84%	0.83%	1.16%	51.20%	1.30%	52.32%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.32	1.27	1.39	1.28	1.38	1.40	1.38	1.29	1.37	1.33	1.27
Quick Ratio	1.09	1.04	1.15	1.06	1.16	1.17	1.16	1.07	1.15	1.11	1.02
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	5.68	-172	26	143	19	333	-193	-205	-470	-599	-786
Operating Cash Flow to CapEx	150.63%	267.72%	134.30%	281.40%	190.09%	219.21%	80.83%	216.15%	172.30%	180.79%	136.56%
Free Cash Flow to Firm to Interest Expense	0.14	-4.33	0.58	2.92	0.37	6.22	-3.61	-4.20	-9.23	-13.65	-22.04
Operating Cash Flow to Interest Expense	8.99	16.58	7.46	13.89	7.50	8.44	3.03	7.43	5.71	6.77	6.19
Operating Cash Flow Less CapEx to Interest Expense	3.02	10.38	1.90	8.95	3.56	4.59	-0.72	3.99	2.40	3.03	1.66
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.11	1.11	1.09	1.08	1.06	1.04	1.03	1.02	1.02	1.01	1.01
Accounts Receivable Turnover	6.83	7.17	6.93	7.05	6.77	6.71	6.78	7.01	7.17	7.12	7.22
Inventory Turnover	34.82	34.34	34.10	33.55	33.30	32.64	32.42	32.48	32.14	31.80	31.78
Fixed Asset Turnover	2.50	2.49	2.46	2.43	2.42	2.37	2.33	2.30	2.29	2.27	2.28
Accounts Payable Turnover	3.89	12.07	4.03	3.86	4.15	11.37	3.92	3.73	3.78	10.44	3.67
Days Sales Outstanding (DSO)	53.45	50.92	52.66	51.77	53.93	54.38	53.83	52.09	50.92	51.27	50.59
Days Inventory Outstanding (DIO)	10.48	10.63	10.70	10.88	10.96	11.18	11.26	11.24	11.35	11.48	11.49
Days Payable Outstanding (DPO)	93.86	30.24	90.62	94.46	87.90	32.11	93.17	97.96	96.62	34.96	99.41
Cash Conversion Cycle (CCC)	-29.92	31.30	-27.26	-31.81	-23.01	33.46	-28.08	-34.63	-34.35	27.79	-37.34
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	11,777	11,548	11,615	11,351	11,435	11,012	11,342	11,158	11,147	11,087	10,931
Invested Capital Turnover	1.39	1.40	1.34	1.33	1.30	1.29	1.26	1.26	1.26	1.25	1.27
Increase / (Decrease) in Invested Capital	342	535	273	194	288	-75	410	416	681	799	994
Enterprise Value (EV)	17,205	16,687	20,287	17,243	17,620	15,208	13,961	16,085	20,068	15,111	11,449
Market Capitalization	12,214	11,836	15,278	12,377	12,441	10,362	8,685	11,015	8,922	9,961	6,373
Book Value per Share	$104.39	$101.06	$99.02	$96.90	$93.10	$90.08	$87.40	$86.73	$0.00	$82.91	$80.24
Tangible Book Value per Share	$43.65	$41.44	$39.58	$38.00	$34.65	$32.47	$31.02	$30.74	($55.38)	$28.16	$27.15
Total Capital	11,904	11,644	11,721	11,480	11,547	11,114	11,422	11,237	11,257	11,174	11,006
Total Debt	5,018	4,881	5,034	4,924	5,236	4,912	5,311	5,104	5,200	5,204	5,097
Total Long-Term Debt	4,978	4,841	4,996	4,796	5,109	4,786	5,185	4,993	5,104	5,122	5,031
Net Debt	4,891	4,755	4,928	4,795	5,124	4,793	5,230	5,025	5,090	5,101	5,023
Capital Expenditures (CapEx)	239	246	248	241	209	206	200	168	169	164	162
Debt-free, Cash-free Net Working Capital (DFCFNWC)	661	520	723	590	811	805	809	621	682	602	509
Debt-free Net Working Capital (DFNWC)	788	646	829	719	923	925	890	701	792	704	584
Net Working Capital (NWC)	747	606	791	591	796	798	763	589	696	623	517
Net Nonoperating Expense (NNE)	26	26	33	42	42	39	49	42	49	30	31
Net Nonoperating Obligations (NNO)	4,891	4,785	4,928	4,795	5,124	4,810	5,230	5,025	5,090	5,117	5,023
Total Depreciation and Amortization (D&A)	148	147	150	147	141	145	137	144	142	148	146
Debt-free, Cash-free Net Working Capital to Revenue	4.11%	3.29%	4.69%	3.93%	5.53%	5.64%	5.77%	4.50%	5.02%	4.49%	3.85%
Debt-free Net Working Capital to Revenue	4.90%	4.08%	5.38%	4.79%	6.30%	6.47%	6.34%	5.08%	5.83%	5.26%	4.41%
Net Working Capital to Revenue	4.65%	3.83%	5.13%	3.94%	5.43%	5.59%	5.44%	4.27%	5.13%	4.65%	3.91%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$4.87	$5.05	$3.89	$4.32	$3.90	$3.18	$2.42	$2.44	$2.31	$2.44	$2.52
Adjusted Weighted Average Basic Shares Outstanding	64.97M	66.55M	66.54M	66.88M	67.20M	69.32M	68.87M	70.07M	70.54M	73.12M	72.60M
Adjusted Diluted Earnings per Share	$4.80	$4.94	$3.80	$4.26	$3.82	$3.13	$2.40	$2.42	$2.28	$2.42	$2.50
Adjusted Weighted Average Diluted Shares Outstanding	66.04M	67.90M	68.11M	67.92M	68.48M	70.13M	69.62M	70.84M	71.49M	73.83M	73.06M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	64.44M	65.00M	65.97M	66.71M	66.93M	67.22M	68.26M	69.39M	70.18M	70.67M	71.41M
Normalized Net Operating Profit after Tax (NOPAT)	348	363	299	336	307	259	217	211	211	200	208
Normalized NOPAT Margin	8.49%	8.83%	7.55%	8.60%	8.00%	6.99%	6.10%	5.95%	6.10%	5.81%	6.24%
Pre Tax Income Margin	10.26%	10.65%	8.62%	9.78%	8.74%	7.59%	6.19%	6.33%	6.17%	6.45%	7.02%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	11.50	12.03	8.65	8.81	7.36	6.25	5.13	5.60	5.21	6.07	7.57
NOPAT to Interest Expense	8.69	9.15	6.70	6.88	5.82	4.83	4.07	4.32	4.15	4.56	5.84
EBIT Less CapEx to Interest Expense	5.53	5.84	3.10	3.88	3.41	2.39	1.38	2.16	1.89	2.32	3.04
NOPAT Less CapEx to Interest Expense	2.72	2.96	1.15	1.94	1.87	0.98	0.33	0.88	0.84	0.82	1.31
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	3.58%	4.03%	4.77%	5.70%	7.22%	8.28%	9.02%	16.01%	16.34%	17.10%	16.03%
Augmented Payout Ratio	65.28%	61.70%	60.48%	66.43%	80.68%	84.37%	82.88%	86.34%	99.00%	143.88%	178.91%

Frequently Asked Questions About Universal Health Services' Financials

When does Universal Health Services's financial year end?

According to the most recent income statement we have on file, Universal Health Services' fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Universal Health Services' net income changed over the last 9 years?

Universal Health Services' net income appears to be on an upward trend, with a most recent value of $1.16 billion in 2024, rising from $750.70 million in 2015. The previous period was $719.31 million in 2023. See where experts think Universal Health Services is headed by visiting Universal Health Services' forecast page.

What is Universal Health Services's operating income?

Universal Health Services's total operating income in 2024 was $1.68 billion, based on the following breakdown:

Total Gross Profit: $8.31 billion
Total Operating Expenses: $6.63 billion

How has Universal Health Services revenue changed over the last 9 years?

Over the last 9 years, Universal Health Services' total revenue changed from $9.04 billion in 2015 to $15.83 billion in 2024, a change of 75.0%.

How much debt does Universal Health Services have?

Universal Health Services' total liabilities were at $7.71 billion at the end of 2024, a 0.8% decrease from 2023, and a 52.2% increase since 2015.

How much cash does Universal Health Services have?

In the past 9 years, Universal Health Services' cash and equivalents has ranged from $33.75 million in 2016 to $1.22 billion in 2020, and is currently $125.98 million as of their latest financial filing in 2024.

How has Universal Health Services' book value per share changed over the last 9 years?

Over the last 9 years, Universal Health Services' book value per share changed from 43.16 in 2015 to 101.06 in 2024, a change of 134.2%.

Related Companies

This page (NYSE:UHS) was last updated on 5/29/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Universal Health Services (UHS) Financials

Frequently Asked Questions About Universal Health Services' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Universal Health Services (UHS) Financials

Annual Income Statements for Universal Health Services

Quarterly Income Statements for Universal Health Services

Annual Cash Flow Statements for Universal Health Services

Quarterly Cash Flow Statements for Universal Health Services

Annual Balance Sheets for Universal Health Services

Quarterly Balance Sheets for Universal Health Services

Annual Metrics And Ratios for Universal Health Services

Quarterly Metrics And Ratios for Universal Health Services

Frequently Asked Questions About Universal Health Services' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools